You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Androgen Receptor Burden and Poor Response to Abiraterone or Enzalutamide in TP53 Wild-Type Metastatic Castration-Resistant Prostate Cancer
|
|---|---|
| Published in |
JAMA Oncology, July 2019
|
| DOI | 10.1001/jamaoncol.2019.0869 |
| Pubmed ID | |
| Authors |
Bram De Laere, Prabhakar Rajan, Henrik Grönberg, Luc Dirix, Johan Lindberg |
X Demographics
The data shown below were collected from the profiles of 65 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 11 | 17% |
| Spain | 7 | 11% |
| Belgium | 6 | 9% |
| Australia | 3 | 5% |
| United Kingdom | 3 | 5% |
| Canada | 3 | 5% |
| Italy | 2 | 3% |
| France | 2 | 3% |
| Singapore | 2 | 3% |
| Other | 6 | 9% |
| Unknown | 20 | 31% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 30 | 46% |
| Scientists | 25 | 38% |
| Practitioners (doctors, other healthcare professionals) | 10 | 15% |
Mendeley readers
The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 32 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 6 | 19% |
| Student > Ph. D. Student | 5 | 16% |
| Other | 3 | 9% |
| Student > Bachelor | 3 | 9% |
| Student > Doctoral Student | 2 | 6% |
| Other | 3 | 9% |
| Unknown | 10 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 10 | 31% |
| Biochemistry, Genetics and Molecular Biology | 7 | 22% |
| Arts and Humanities | 1 | 3% |
| Computer Science | 1 | 3% |
| Business, Management and Accounting | 1 | 3% |
| Other | 2 | 6% |
| Unknown | 10 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 70. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 January 2021.
All research outputs
#619,973
of 25,726,194 outputs
Outputs from JAMA Oncology
#976
of 3,350 outputs
Outputs of similar age
#13,008
of 361,195 outputs
Outputs of similar age from JAMA Oncology
#41
of 94 outputs
Altmetric has tracked 25,726,194 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,350 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 84.1. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,195 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 94 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.